HER2 target therapy

DRUG2 trials

Sponsors

Zhejiang University, Peking University People's Hospital

Conditions

Bile Duct CarcinomaBreast Cancer (Early Breast Cancer)Cholangiocarcinoma

Phase 2

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

Not yet recruitingNCT07729917

Zhejiang UniversityBile Duct Carcinoma, Cholangiocarcinoma

Start: 2026-08-10End: 2030-12-31Target: 240Updated: 2026-07-28

ADC Based Therapy Accroding to HER2 Heterogeneous

Not yet recruitingNCT07844018

Peking University People's HospitalBreast Cancer (Early Breast Cancer)

Start: 2027-01-01End: 2029-06-30Target: 88Updated: 2026-10-02